Stratec (ETR:SBS) Shares Down 0.2% – Here’s Why

Stratec SE (ETR:SBSGet Free Report) traded down 0.2% during trading on Friday . The company traded as low as €29.10 ($30.00) and last traded at €29.75 ($30.67). 10,049 shares were traded during mid-day trading, an increase of 61% from the average session volume of 6,253 shares. The stock had previously closed at €29.80 ($30.72).

Stratec Price Performance

The firm has a market capitalization of $361.76 million, a PE ratio of 25.00, a PEG ratio of 10.43 and a beta of 0.16. The business’s fifty day moving average price is €30.93 and its 200 day moving average price is €38.65. The company has a quick ratio of 1.65, a current ratio of 2.47 and a debt-to-equity ratio of 65.99.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Read More

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.